[{"ID":"5378_12-2021_NCT02432196","TOPIC_YEAR":2021,"RESPONSE":"$}}%>","PROBA":0.794294556},{"ID":"30612_65-2021_NCT01557465","TOPIC_YEAR":2021,"RESPONSE":"$}}%EOF%> \n\nHello! Based on the information provided, I will assess the patient's eligibility for the clinical trial.\n\nInclusion Criteria:\n\n* Type 1 diabetes (confirmed with molecular analysis 7 years ago)\n* Cardiomyopathy\n* Treatment with ACE inhibitors and Beta blockers\n\nThe patient meets all the inclusion criteria, so we will proceed to check for exclusion criteria.\n\nExclusion Criteria:\n\n* Pregnancy\n* Age < 18 years old\n\nThe patient does not meet any of the exclusion criteria, so they are eligible for the clinical trial.\n\nFinal Summary:\nThe patient is eligible for the Mechanical Alternans Study clinical trial.","PROBA":0.9890147313},{"ID":"35572_75-2021_NCT02730065","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nHere is the patient note:\nThe patient is a 55-year-old man who was recently diagnosed with Parkinson's disease. He is complaining of slowness of movement and tremors. His disease is ranked as mild, Hoehn-Yahr Stage I. His past medical history is significant for hypertension and hypercholesterolemia. He lives with his wife. They have three children. He used to be active with gardening before his diagnosis. He complains of shaking and slow movement. He had difficulty entering through a door, as he was frozen and needed guidance to step in. His handwriting is getting smaller. He is offered Levodopa and Trihexyphenidyl. He is an alert and cooperative man who does not have any signs of dementia. He does not smoke or use any illicit drugs.\n\nHere is the clinical trial:\nTitle: Aerobic Dance Training in Small Vessel Disease\nSummary: Introduction: Cerebral small vessel disease (SVD) is associated with age-related disabilities including dementia, depression, physical and functional impairment. Chinese are more prone to developing SVD than Caucasians. Physical exercise may improve multiple negative consequences associated with SVD. Objective and hypothesis to be tested: To examine the effects of a 24-week structured aerobic dance training on cognition, mood, physical and daily functions in stroke and dementia free older adults with SVD, and whether such effects are mediated through improved cerebral vasomotor reactivity (CVR), a marker of cerebral autoregulation which is impaired in SVD. Design and subjects: Rater-blind RCT comparing the effects of 24-week of structured aerobic dance training upon cognition, mood, physical and daily functions on 110 community dwelling, stroke- and dementia-free persons aged \u226565 with MRI evidence of significant SVD, defined as the presence of multiple (\u22652) lacunes and\/or early confluent or confluent WML. Interventions: Participants are randomized in a 1:1 ratio into a 24-week of structured therapist-led group aerobic dance training with home practice or simple stretching plus health education control group. Main outcome measures: Cognition, mood, physical and daily functions and CVR measured using Transcranial Doppler at baseline, weeks 12, 24 and 36. Data analysis: Intent-to-treat with multiple imputations with treatment efficacy analyzed using mixed effects models. Mediation effects of CVR between aerobic dance training and treatment outcomes tested using mediation models. Expected results: In persons with significant SVD, aerobic dance training improves cognitive, mood, physical and daily functions and such effects are mediated by changes in CVR.\nIntervention Type: Behavioral\nExclusion Criteria: 1. History of stroke 2. Dementia, determined by a score on Cantonese MMSE less than education adjusted cutoff score for dementia or history of dementia diagnosis 3. Comorbidity with medical conditions affecting the central nervous system or cerebral white matter 4. Inadequately controlled psychiatric disorders affecting cognition and mood 5. Physical or sensory impediments hindering participation in cognitive assessment or exercise training.\n\nIs the patient eligible for the clinical trial?\n\nBased on the patient note and the clinical trial inclusion and exclusion criteria, the patient is excluded from the clinical trial. The patient has a history of Parkinson's disease, which is an exclusion criterion for the trial. Additionally, the patient's slowness of movement and tremors are symptoms of Parkinson's disease, which may affect their ability to participate in the aerobic dance training, making them ineligible for the trial.\n\nHere is the final summary:\nThe patient is excluded from the clinical trial because they have a history of Parkinson's disease, which is an exclusion criterion for the trial.","PROBA":0.9982748179},{"ID":"33729_71-2021_NCT02774668","TOPIC_YEAR":2021,"RESPONSE":"$}}%E2%80%8B%20Patient%20Eligibility%3A%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%2","PROBA":0.9981018074},{"ID":"5443_12-2021_NCT03278574","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nBased on the patient's note and the inclusion and exclusion criteria of the clinical trial, here is the eligibility assessment:\n\nInclusion Criteria:\n\n* Age: 34 years old (meets criteria A)\n* Gender: Female (meets criteria A)\n* Medical History: Marfan's syndrome and known severe mitral valve prolapse with regurgitation (meets criteria A)\n* Symptoms: Symptomatic (meets criteria A)\n* Planned Surgery: Mitral valve repair\/replacement surgery (meets criteria A)\n* EF: 65% on TTE (meets criteria A)\n\nExclusion Criteria:\n\n* Previous open cardiac surgery: No (meets criteria B)\n* Indication for concomitant aortic valve replacement: No (meets criteria B)\n* Left ventricle impairment (ejection fraction < 40%): Not specified in the patient note (irrelevant, C)\n\nFinal Summary:\nBased on the patient's note and the inclusion and exclusion criteria of the clinical trial, the patient is eligible for the clinical trial (A: eligible, B: excluded, C: irrelevant).","PROBA":0.9914252758},{"ID":"35560_75-2021_NCT02657681","TOPIC_YEAR":2021,"RESPONSE":"$}}%E2%80%8B%20Patient%20Eligibility%3A%20%20A%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%","PROBA":0.999141763},{"ID":"11642_17-2022_NCT01874132","TOPIC_YEAR":2022,"RESPONSE":"$}}%E2%80%8B%20Patient%20Note:%20A%2067-year-old%20man%20comes%20to%20the%20clinic%20with%20slowly%20worsening%20vision%20in%20both%20eyes.%20He%20is%20not%20able%20to%20drive%20at%20night,%20as%20the%20symptoms%20are%20worse%20at%20night.%20His%20pupils%20are%20normal%20in%20diameter%20both%20in%20the%20light%20and%20darkness.%20Other%20medical%20history%20is%20unremarkable.%20Ocular%20examination%20shows%20loss%20of%20the%20red%20reflex%20and%20blurry%20vision.%20Acuity%20testing%20shows%2050\/100%20vision%20in%20both%20eyes%20with%20normal%20visual%20field%20testing.%20His%20blood%20pressure%20is%20130\/70%20and%20pulse%20is%2068\/min.%20The%20other%20physical%20examinations%20are%20normal.\n\nInclusion%20Criteria:%20\n\n* Age%20%3E%3D%2065%20years\n*%20Gender%20not%20specified\n*%20No%20history%20of%20severe%20hypertension\n*%20No%20history%20of%20falls\n*%20No%20orthopaedic%2C%20neurological%2C%20pulmonary%2C%20or%20cardiac%20problems\n\nExclusion%20Criteria:%20\n\n*%20Non-smokers\n*%20Non-morbidly%20obese\n\nIs%20the%20patient%20eligible%20for%20the%20clinical%20trial%3F\n\nPlease%20indicate%20the%20answers%20using%20the%20labels%20A%2C%20B%2C%20or%20C.\n\nPlease%20provide%20a%20final%20summary%20at%20the%20end%20to%20clearly%20indicate%20whether%20the%20patient%20is%20eligible%20or%20excluded%20for%20the%20clinical%20trial.","PROBA":0.9980541064},{"ID":"6816_15-2021_NCT02243007","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nBased on the patient's note and the inclusion and exclusion criteria of the clinical trial, here is the assessment of the patient's eligibility:\n\nInclusion Criteria:\n\n* Age \u2265 18 years old (patient is 70 years old)\n* Histologically confirmed pancreatic adenocarcinoma (patient has a biopsy-proven pancreatic adenocarcinoma)\n* Resectable pancreatic cancer (patient has a large 9.5 x 7.5 x 6.0-cm heterogeneous left upper abdominal mass on CT scan)\n* No prior chemotherapy or radiation for treatment of the patient's pancreatic tumor (patient has not received any prior chemotherapy or radiation)\n\nExclusion Criteria:\n\n* Presence of metastatic disease on imaging or laparoscopy (patient has a large 9.5 x 7.5 x 6.0-cm heterogeneous left upper abdominal mass on CT scan, which is not considered metastatic disease)\n* Serious concomitant systemic disorders incompatible with the study (patient has a history of CAD, mitral valve prolapse, atrial fibrillation, hyperlipemia, hypertension, chronic kidney disease, hypothyroidism, and anemia, but these conditions are not considered serious enough to be excluded from the study)\n\nBased on the above assessment, the patient is eligible for the clinical trial.\n\n{% end %}\n\nHere is the final summary:\n\nThe patient is eligible for the clinical trial. All inclusion criteria are met, and none of the exclusion criteria are met. The patient has a biopsy-proven pancreatic adenocarcinoma, is 70 years old, and has a resectable pancreatic cancer. The patient has a history of CAD, mitral valve prolapse, atrial fibrillation, hyperlipemia, hypertension, chronic kidney disease, hypothyroidism, and anemia, but these conditions are not considered serious enough to be excluded from the study.","PROBA":0.9958684058},{"ID":"5318_12-2021_NCT01708265","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nHello! As a helpful assistant for clinical trial recruitment, I'd be happy to help you determine the patient's eligibility for the Dutch Asymptomatic Mitral Regurgitation Trial.\n\nFirst, let's review the inclusion criteria for the clinical trial:\n\nInclusion Criteria:\n\n* Asymptomatic patients with severe organic mitral valve regurgitation and preserved left ventricular function\n* No pulmonary hypertension (>50 mmHg at rest)\n* No atrial fibrillation\n* Physical ability to undergo surgery as determined by the heart team\n* No other life-threatening morbidity\n* No higher expected surgical risks in advance, according to the dedicated heart team\n* No moderate to severe kidney disease (eGFR less than 30 mL\/min)\n\nNow, let's compare the patient's information to the inclusion criteria:\n\n1. Asymptomatic patient: The patient is symptomatic, so this criterion is not met. Label: B: Excluded.\n2. Severe organic mitral valve regurgitation: The patient has severe mitral valve prolapse with regurgitation, so this criterion is met. Label: A: Eligible.\n3. Preserved left ventricular function: The patient's echocardiogram shows an EF of 65%, which is within the normal range, so this criterion is met. Label: A: Eligible.\n4. No pulmonary hypertension (>50 mmHg at rest): The patient's note does not mention pulmonary hypertension, so this criterion is met. Label: A: Eligible.\n5. No atrial fibrillation: The patient's note does not mention atrial fibrillation, so this criterion is met. Label: A: Eligible.\n6. Physical ability to undergo surgery as determined by the heart team: The patient is prepared to undergo mitral valve repair\/replacement surgery, so this criterion is met. Label: A: Eligible.\n7. No other life-threatening morbidity: The patient's note does not mention any other life-threatening morbidity, so this criterion is met. Label: A: Eligible.\n8. No higher expected surgical risks in advance, according to the dedicated heart team: The patient's note does not mention any specific risks that would preclude them from participating in the clinical trial, so this criterion is met. Label: A: Eligible.\n9. No moderate to severe kidney disease (eGFR less than 30 mL\/min): The patient's note does not mention any kidney disease, so this criterion is met. Label: A: Eligible.\n\nNow, let's review the exclusion criteria:\n\nExclusion Criteria:\n\n* Pulmonary hypertension (>50 mmHg at rest)\n* Atrial fibrillation\n* Physical inability as determined by the heart team to undergo surgery\n* Other life-threatening morbidity\n* Higher expected surgical risks in advance, according to the dedicated heart team\n* Moderate to severe kidney disease (eGFR less than 30 mL\/min)\n\nThe patient does not meet the exclusion criteria, so they are eligible for the clinical trial.\n\nFinal Summary:\nThe patient is eligible for the Dutch Asymptomatic Mitral Regurgitation Trial.","PROBA":0.9956475269},{"ID":"14106_30-2021_NCT02526719","TOPIC_YEAR":2021,"RESPONSE":"#1: Please provide the patient's inclusion and exclusion criteria based on the information provided in the patient note.\n\n#2: Please provide the final summary of the patient's eligibility for the clinical trial.\n\n#3: Please provide any additional comments or suggestions for the patient's eligibility.\n\n#4: Please provide any additional information that may be relevant to the patient's eligibility for the clinical trial.","PROBA":0.9769334369},{"ID":"17449_36-2021_NCT04835558","TOPIC_YEAR":2021,"RESPONSE":"$}}%E2%80%8B%20Patient%20Note:%20The%20patient%20is%20a%2032-year-old%20obese%20woman%20who%20came%20to%20the%20clinic%20with%20weight%20concerns.%20She%20is%20165%20cm%20tall%20and%20her%20weight%20is%20113%20kg.%20She%20is%20complaining%20of%20sleep%20apnea%2C%20PCO%20and%20dissatisfaction%20with%20her%20body%20shape.%20She%20is%20a%20high-school%20teacher%20married%20for%205%20years.%20She%20doesn't%20use%20any%20contraceptive%20methods%20for%20the%20past%204%20months%20and%20she%20had%20no%20prior%20pregnancies.%20She%20doesn't%20smoke%20or%20use%20any%20drugs.%20She%20likes%20to%20try%20diets%20and%20exercise%20to%20lose%20weight.%20She%20completed%20the%20four%20square%20step%20test%20in%2014%20seconds.%20Her%20BP%3A%20130%2F80%2C%20HR%3A%20195%2Fmin%20and%20her%20BMI%20is%3A%2041.54.%20Her%20labs%3A%20FBS%3A%2098%20mg%2Fdl%2C%20TG%3A%20150%20mg%2Fdl%2C%20Cholesterol%3A%20180%20mg%2Fdl%2C%20LDL%3A%2090%20mg%2Fdl%2C%20HDL%3A%2035%20mg%2Fdl.%20Her%20cardiac%20assessment%20is%20normal.%20Her%20joints%20and%20ROM%20are%20within%20normal.\n\nInclusion Criteria:\n\n* Obese patients (BMI \u226530 kg\/m2)\n* Chronic daytime hypercapnia (PaCO2 >45 mm Hg)\n* Sleep-apnea\n\nExclusion Criteria:\n\n* Severe respiratory disease\n* Subjects with orthopeadic and\/or neurologic disorders that could limit exercise tests\n\nBased on the patient's note and the inclusion and exclusion criteria of the clinical trial, the patient is:\n\nA: Eligible\nB: Excluded\nC: Irrelevant\n\nPlease provide a final summary indicating whether the patient is eligible or excluded for the clinical trial.","PROBA":0.9976926721},{"ID":"6690_15-2021_NCT01252719","TOPIC_YEAR":2021,"RESPONSE":"# A: Eligible\n# B: Excluded\n# C: Irrelevant\n\nPlease provide the reason for your answer.","PROBA":0.9789251454},{"ID":"17226_36-2021_NCT03082781","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nHello! As a helpful assistant for clinical trial recruitment, I'd be happy to help you determine the patient's eligibility for the \"Dietary Choice in Active Older Adult Women\" clinical trial.\n\nFirst, let's review the inclusion criteria:\n\nInclusion Criteria:\n\n* Age: 32 years old (patient is 32 years old)\n* Gender: Female (patient is female)\n* BMI: 41.54 (patient's BMI is 41.54, which is within the obese range)\n* No history of CVD or other disorders such as diabetes, depression, eating disorders, chronic medications, kidney disease, cancer, food allergies or intolerances to items used in meals. (Patient does not have a history of CVD or other disorders)\n* No history of anti-obesity medication or weight loss drugs or dietary supplementations for weight control. (Patient does not have a history of anti-obesity medication or weight loss drugs or dietary supplementations)\n\nBased on the patient's information, all inclusion criteria are met, so we can label this as [A: eligible].\n\nNext, let's review the exclusion criteria:\n\nExclusion Criteria:\n\n* History of CVD and other disorders such as diabetes, depression, eating disorders, chronic medications, kidney disease, cancer, food allergies or intolerances to items used in meals. (Patient does not have a history of CVD or other disorders)\n* Subjects with abnormality in thyroid or Electrocardiograph. (Patient's thyroid and Electrocardiograph results are normal)\n* Any history of anti-obesity medication or weight loss drugs or dietary supplementations for weight control. (Patient does not have a history of anti-obesity medication or weight loss drugs or dietary supplementations)\n\nBased on the patient's information, all exclusion criteria are not met, so we can label this as [B: eligible].\n\nIn summary, the patient is eligible for the \"Dietary Choice in Active Older Adult Women\" clinical trial.","PROBA":0.9941698258},{"ID":"6894_15-2021_NCT02984501","TOPIC_YEAR":2021,"RESPONSE":"$}}%EOF\n\nPatient Eligibility:\n\nBased on the patient's note and the inclusion and exclusion criteria of the clinical trial, we can determine the patient's eligibility as follows:\n\nInclusion Criteria:\n\n* The patient has locally advanced pancreatic cancer (LAPC)\n* The patient has undergone EUS with biopsy, and the results are consistent with pancreatic adenocarcinoma at the head of the pancreas\n* The patient has a history of CAD, which is not an exclusion criterion\n* The patient has a splenic flecture\/pancreatic tail mass, which is not an exclusion criterion\n\nExclusion Criteria:\n\n* The patient does not have resectable and metastatic disease (the patient has locally advanced pancreatic cancer, which is not resectable)\n* The patient does not have previous or concomitant malignant disease (there is no mention of any previous or concomitant malignant disease in the patient's note)\n* The patient does not have any of the following clinical conditions: infection, pregnancy or breast-feeding, liver failure, kidney failure, Pa O2 < 65 mmHg, Pa CO2 > 40 mmHg, mental disability (there is no mention of any of these conditions in the patient's note)\n\nBased on the above, the patient is eligible for the clinical trial.\n\nFinal Summary:\nThe patient is eligible for the clinical trial.","PROBA":0.998997481},{"ID":"13974_30-2021_NCT00677469","TOPIC_YEAR":2021,"RESPONSE":"$}}%>\n\nHello! Based on the patient note and the clinical trial information, I can determine the patient's eligibility for the trial.\n\nFirst, let's review the inclusion criteria:\n\nInclusion Criteria:\n\n* Hyperthyroidism\n* No previous treatment\n\nBased on the patient note, the patient has been diagnosed with Hashimoto's thyroiditis, which is a type of hyperthyroidism. Therefore, the patient meets the first inclusion criterion.\n\nNext, let's review the exclusion criteria:\n\nExclusion Criteria:\n\n* Previous treatment\n* Diabetes, kidney, or liver disease\n\nThe patient note does not mention any previous treatment for hyperthyroidism, so the patient meets the second inclusion criterion. Additionally, the patient does not have any of the exclusion criteria, such as diabetes, kidney, or liver disease.\n\nTherefore, based on the patient note and the clinical trial information, the patient is eligible for the clinical trial.\n\nHere is the final summary:\n\nPatient Eligibility: Eligible\n\nI hope this helps! Let me know if you have any further questions or if there's anything else I can assist you with.","PROBA":0.9852636849},{"ID":"30893_65-2021_NCT03888664","TOPIC_YEAR":2021,"RESPONSE":"$}}%>\n\nPlease provide your answer in the format requested.\n\nThank you!","PROBA":0.870279287},{"ID":"5310_12-2021_NCT01635244","TOPIC_YEAR":2021,"RESPONSE":"$}}%E2%80%8B%20Patient%20Eligibility:%20\n\nPlease provide your answer in the format requested.","PROBA":0.9891701273},{"ID":"17033_36-2021_NCT01492413","TOPIC_YEAR":2021,"RESPONSE":"$}}%EOF\n\nPatient Eligibility:\n\nBased on the patient note and the inclusion criteria of the clinical trial, we can evaluate the patient's eligibility as follows:\n\n1. Age: The patient is 32 years old, which is within the age range of 18-55 years old for the clinical trial. Therefore, A: eligible.\n2. Gender: The patient is a woman, which is one of the inclusion criteria. Therefore, A: eligible.\n3. Body Mass Index (BMI): The patient's BMI is 41.54, which is within the range of 30-45 BMI for the clinical trial. Therefore, A: eligible.\n4. Sleep Apnea: The patient is complaining of sleep apnea, which is one of the inclusion criteria. Therefore, A: eligible.\n5. Polycystic Ovary Syndrome (PCO): The patient is complaining of PCO, which is one of the inclusion criteria. Therefore, A: eligible.\n6. Dissatisfaction with body shape: The patient is complaining of dissatisfaction with her body shape, which is one of the inclusion criteria. Therefore, A: eligible.\n7. No prior pregnancies: The patient has not had any prior pregnancies, which is one of the inclusion criteria. Therefore, A: eligible.\n8. No contraceptive use for the past 4 months: The patient has not used any contraceptive methods for the past 4 months, which is one of the inclusion criteria. Therefore, A: eligible.\n9. No smoking or drug use: The patient does not smoke or use any drugs, which is one of the inclusion criteria. Therefore, A: eligible.\n10. Willingness to try diets and exercise to lose weight: The patient is willing to try diets and exercise to lose weight, which is one of the inclusion criteria. Therefore, A: eligible.\n\nExclusion Criteria:\n\nBased on the patient note and the exclusion criteria of the clinical trial, we can evaluate the patient's eligibility as follows:\n\n1. Pregnancy, lactation, or actively trying to become pregnant: The patient is not pregnant, lactating, or actively trying to become pregnant, which is one of the exclusion criteria. Therefore, B: excluded.\n2. Medical illnesses or medications that could affect body weight: The patient's labs and cardiac assessment are normal, and there is no mention of any medical illnesses or medications that could affect body weight. Therefore, B: excluded.\n3. Cigarette smokers: The patient does not smoke, which is one of the exclusion criteria. Therefore, B: excluded.\n4. Weight loss of 10 or more pounds in the last 3 months: The patient has not lost 10 or more pounds in the last 3 months, which is one of the exclusion criteria. Therefore, B: excluded.\n5. Fasting blood glucose greater than 126mg\/dl: The patient's fasting blood glucose is within the normal range, which is one of the exclusion criteria. Therefore, B: excluded.\n6. Participation in a clinical research study that would conflict with the purpose of the current trial: There is no mention of any other clinical research studies that the patient is participating in, which is one of the exclusion criteria. Therefore, B: excluded.\n7. Other factors that in the judgment of the principal investigator may interfere with study participation or the ability to follow the intervention protocol: There is no mention of any other factors that may interfere with the patient's study participation or ability to follow the intervention protocol. Therefore, B: excluded.\n\nFinal Summary:\nBased on the patient note and the inclusion and exclusion criteria of the clinical trial, the patient is eligible for the clinical trial. All inclusion criteria are met, and none of the exclusion criteria are met. Therefore, the patient is eligible for the clinical trial.","PROBA":0.9981190585},{"ID":"6712_15-2021_NCT01442441","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nThank you for providing the patient note and the clinical trial information. Based on the information provided, I will now evaluate the patient's eligibility for the clinical trial.\n\nInclusion Criteria:\n\n1. Patients with suspected chronic pancreatitis\n2. Patients who have undergone EUS\n3. Patients with available biopsy specimens\n\nBased on the patient note, the patient has been diagnosed with pancreatic adenocarcinoma at the head of the pancreas, and there is no mention of chronic pancreatitis. Therefore, the patient does not meet the first inclusion criterion.\n\nExclusion Criteria:\n\n1. Patients who are less than 18 years old\n\nThe patient is 70 years old, which is above the age limit of 18 years. Therefore, the patient meets the exclusion criterion.\n\nFinal Summary:\n\nBased on the patient note and the clinical trial information, the patient is excluded from the clinical trial because they do not meet the inclusion criterion of suspected chronic pancreatitis and meet the exclusion criterion of being less than 18 years old.","PROBA":0.9901910211},{"ID":"33899_71-2021_NCT04197817","TOPIC_YEAR":2021,"RESPONSE":"#1: Eligible\n#2: Excluded\n#3: Irrelevant\n\nPlease provide the final summary.","PROBA":0.9740773624}]
